27/07/2004 - 22:00

Acuron listing

27/07/2004 - 22:00

Bookmark

Upgrade your subscription to use this feature.
Acuron listing

Medical products company Acuron is planning to relist on the Australian Stock Exchange as WA Business News goes to press.

The company received strong shareholder support at a general meeting on July 7 to change its name from Auridiam to Acuron and to change its activities from diamond exploration to sale of Vacutex wound care.

Vacutex is a treatment for wounds such as ulcers. It has a wicking effect that draws moisture away from such wounds, improving recovery times.

Acuron managing director George Cameron-Dow said sales of Vacutex were underway in the UK where the product was National Health Service-registered, in Australia where it has Therapeutic Goods Administration approval and in the Middle East.

"The advanced wound care market is worth more than $55 million in Australia and more than $US1.4 billion worldwide and the sector is forecast to grow at an annual rate of between 7 per cent and 11 per cent.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options